Children's National Medical Center
- Advisory Board: Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.; Otsuka America Pharmaceutical, Inc.; Shionogi Pharma, Inc. (formerly Sciele Pharmaceuticals)
- Consultant: Bristol-Myers Squibb; Eli Lilly and Company; Forest Laboratories, Inc.; Lundbeck; Otsuka America Pharmaceutical, Inc.; Shionogi Pharma, Inc. (formerly Sciele Pharmaceuticals)
- Grant Support: Bristol-Myers Squibb; Eunice Kennedy Shriver National Institute of Child Health and Human Development ; Forest Laboratories, Inc.; GlaxoSmithKline; Merck & Co., Inc., Schering-Plough; Otsuka America Pharmaceutical, Inc.; Sepracor Inc.; Supernus Pharmaceuticals, Inc.
- Honorarium for participation in this meeting: American Academy of Child & Adolescent Psychiatry; American Academy of Child and Adolescent Psychiatry
- Research Support: Bristol-Myers Squibb; Janssen, Division of Ortho-McNeil Janssen Pharmaceuticals, Inc.; Pfizer Inc
- Royalties: Epocrates, Inc.
- Speakers Bureau: Eli Lilly and Company; Forest Laboratories, Inc.; McNeil Pediatrics, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
- Travel Support to attend this meeting: American Academy of Child & Adolescent Psychiatry